Pembrolizumab-Induced Toxic Epidermal Necrolysis

Pembrolizumab-Induced Toxic Epidermal Necrolysis

Immunotherapy has nowadays become part of the mainstay of treatment for several cancers. In this report, we present a case of toxic epidermal necrolysis (TEN) occurring as a relatively rare complication of pembrolizumab, which is a humanized monoclonal anti-programmed cell death-1 (anti-PD1) IgG4 an...

Full description

Bibliographic Details
Main Authors: Luca Borg, Malcolm Buhagiar, Elisa La Ferla, David Pisani, Janabel Said, Michael J. Boffa
Format: Article
Language:English
Published: Karger Publishers 2022-10-01
Series:Case Reports in Oncology
Subjects:
pembrolizumab
toxic epidermal necrolysis
steroids
intravenous immuoglobulin
cyclosporin
non-small cell lung cancer
immunotherapy
Online Access:https://www.karger.com/Article/FullText/526931

Internet

https://www.karger.com/Article/FullText/526931

Similar Items